Bemarituzumab Regimen Improves Survival in FGFR2b+ Gastric/GEJ Cancer
Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.
Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis
Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.
Video-Based Genetic Counseling Improves Comprehension in HBOC
In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.
Practice-Changing Lung Cancer Data From the 2025 ASCO Annual Meeting
Stephen Liu, MD; and Joshua Sabari, MD, discuss the most intriguing non–small cell lung cancer and small cell lung cancer breakthroughs from the meeting.
16 A Miami Hospital’s Infrastructure to Help Decrease Late-Stage Breast Cancer Diagnosis and Improve Health Equity
Comparing CAR T Safety, Efficacy in Relapsed/Refractory Multiple Myeloma
The expert panel discussed the efficacy observed with cilta-cel in patients with relapsed/refractory multiple myeloma.
